Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18931,130,1.29 [0.99-1.69],0.0608560350128705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19752,150,1.09 [0.81-1.48],0.556113728898713
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19543,1129,1.00 [0.89-1.13],0.9614203891828504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,19759,290,1.00 [0.79-1.27],0.9799433471714404
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19175,2796,1.01 [0.93-1.09],0.8276868688648913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19165,2817,1.01 [0.94-1.09],0.7753218979342499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19583,852,1.02 [0.89-1.16],0.792771257890003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19704,66,1.14 [0.74-1.77],0.5411227685289457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17947,880,1.02 [0.89-1.16],0.8126249023995733
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17308,963,1.05 [0.93-1.19],0.4005684182250355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17124,192,0.96 [0.71-1.30],0.7890195240792977
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13883,1822,1.02 [0.93-1.12],0.7259707484335601
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17069,326,1.08 [0.88-1.33],0.4603187094176686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19752,1021,1.03 [0.91-1.16],0.643621524275842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,19831,362,0.96 [0.78-1.20],0.732950430349801
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19124,710,1.01 [0.87-1.17],0.9260462693666172
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19770,969,1.06 [0.94-1.19],0.3767155639815569
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18883,152,1.09 [0.80-1.47],0.5942678206754591
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19864,40,1.41 [0.92-2.15],0.1184063597016445
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19646,845,1.03 [0.90-1.17],0.7061960198311252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19689,51,1.19 [0.75-1.88],0.4644825067442173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19808,97,1.26 [0.93-1.71],0.1296486590046755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19794,83,1.22 [0.86-1.73],0.2607474744613393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18803,389,1.09 [0.90-1.31],0.3785246112155205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18646,232,0.98 [0.75-1.28],0.8759162063730129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18800,69,0.87 [0.51-1.49],0.6111336794388367
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19846,56,0.46 [0.21-1.01],0.0522196202469925
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19816,124,1.08 [0.77-1.51],0.6603823357608456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral warts,19738,46,1.21 [0.75-1.94],0.427285226519436
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19737,45,1.09 [0.62-1.91],0.7647164696584436
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,19605,289,0.88 [0.68-1.13],0.308753314621118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19806,41,0.70 [0.32-1.52],0.3617177526982934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19774,49,0.97 [0.55-1.72],0.9105017037314754
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,0.84 [0.55-1.29],0.4318892979129157
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19553,1363,0.91 [0.81-1.02],0.106123229701641
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of meninges,19863,25,0.76 [0.29-2.02],0.5868359577966673
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19814,56,1.12 [0.70-1.79],0.6323441538797936
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19852,65,0.65 [0.34-1.25],0.1945072406980929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19842,380,1.08 [0.89-1.30],0.4261163904696415
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Caecum,19844,287,0.79 [0.60-1.04],0.0921174361815667
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19755,62,1.22 [0.81-1.84],0.3344238485771001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Descending colon,19840,241,0.77 [0.57-1.05],0.099042044795557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,19803,347,0.90 [0.71-1.14],0.3795626624735659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19761,617,0.96 [0.82-1.14],0.6540655949073262
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19830,460,1.00 [0.83-1.20],0.993833094767597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15485,61,1.00 [0.61-1.65],0.9928512249802974
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15482,58,0.60 [0.30-1.20],0.146347341504314
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19837,79,1.23 [0.87-1.75],0.2407132933033016
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",19837,76,1.21 [0.84-1.75],0.3073695625615871
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lung cancer and mesothelioma,13247,297,0.88 [0.69-1.13],0.3248048475896587
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lymphoid leukaemia,15480,56,0.95 [0.55-1.64],0.8604289495347969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15585,161,1.05 [0.78-1.40],0.7429523669858372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15662,238,0.79 [0.58-1.07],0.1326017869178184
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15500,76,0.99 [0.63-1.57],0.964782597931062
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15530,106,0.88 [0.57-1.34],0.5442174992868313
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15545,121,0.82 [0.54-1.25],0.3600565762451142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15494,70,0.48 [0.24-0.95],0.0352668535657359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.81 [0.70-0.93],0.002258707332196
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15551,127,1.23 [0.93-1.63],0.1462364024381393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15513,89,0.72 [0.42-1.22],0.222599632506548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15526,102,0.92 [0.61-1.38],0.6750489587899022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,19766,145,0.84 [0.58-1.22],0.3690523696084385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of trunk,19838,85,0.62 [0.35-1.10],0.1017801892494164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanoma in situ,15452,62,0.97 [0.58-1.61],0.9004081538532008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15509,85,0.71 [0.41-1.21],0.2079222355009338
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15563,139,0.85 [0.58-1.24],0.3950305389587312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15616,192,0.72 [0.49-1.04],0.076383531936354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15510,86,0.84 [0.51-1.36],0.4679765613932436
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,19753,123,1.12 [0.82-1.53],0.4785021612244635
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16411,987,0.91 [0.80-1.04],0.1808476148128026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16472,1048,0.93 [0.81-1.05],0.2367721148921211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19636,243,1.00 [0.77-1.29],0.9948050973142344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18462,63,1.15 [0.76-1.75],0.503293493241783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19450,57,1.17 [0.75-1.80],0.4920687146303886
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19434,2247,1.04 [0.96-1.13],0.3075873516360023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18854,51,1.18 [0.73-1.91],0.509610685714183
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19517,42,0.78 [0.37-1.63],0.5076287331014663
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19590,1191,1.05 [0.94-1.17],0.4233006177914242
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19588,1189,1.05 [0.94-1.17],0.4135448201883062
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18476,77,1.09 [0.71-1.68],0.6770018417156641
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19679,876,1.00 [0.87-1.14],0.9848439105991764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19564,89,1.03 [0.69-1.55],0.8693471971999145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19453,60,1.45 [1.06-1.98],0.0193234432960592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19448,55,1.20 [0.77-1.86],0.4277347926411047
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19728,253,1.04 [0.81-1.32],0.7681435391673449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19783,38,1.19 [0.71-1.98],0.5116124057787683
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19682,207,1.01 [0.76-1.33],0.960328106987144
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18862,59,0.83 [0.46-1.49],0.5343910898496141
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14719,301,1.23 [1.02-1.49],0.0312761586261997
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18154,136,0.87 [0.60-1.27],0.4834860425782842
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18175,157,1.07 [0.80-1.42],0.6702240931115577
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14466,48,1.07 [0.62-1.85],0.8092148978914088
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18748,53,0.47 [0.21-1.06],0.0694427109436303
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18129,177,1.09 [0.82-1.44],0.5706088921703503
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19484,471,0.91 [0.74-1.11],0.3413714507960559
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19205,192,0.94 [0.69-1.26],0.6635314022604395
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19127,114,1.04 [0.73-1.49],0.8199860364006762
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19614,919,0.99 [0.87-1.13],0.9145216398788544
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17026,887,1.00 [0.87-1.14],0.9918802133663552
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14479,61,0.78 [0.42-1.43],0.4192413500318771
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19171,36,0.65 [0.27-1.56],0.338838946270419
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14635,217,0.90 [0.67-1.21],0.491408848403188
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14479,61,1.45 [1.05-2.01],0.0244733544666493
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17619,3201,1.03 [0.96-1.10],0.4715317382510349
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14571,153,0.75 [0.51-1.12],0.1573503292249908
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14876,458,0.93 [0.76-1.13],0.4574338637287001
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19818,218,1.03 [0.79-1.33],0.8397823798203086
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19666,66,0.53 [0.27-1.06],0.0745880394966405
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14543,125,0.92 [0.63-1.34],0.6554159394952395
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14471,53,1.15 [0.71-1.88],0.5717139413429637
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19713,578,1.02 [0.87-1.20],0.7948032150141672
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14654,236,1.05 [0.83-1.32],0.6725943792455817
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14696,278,1.04 [0.82-1.32],0.7260591275904111
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15014,596,0.94 [0.79-1.12],0.4873968360246429
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14531,113,1.31 [0.98-1.75],0.0709218961781274
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19661,61,0.60 [0.30-1.20],0.1465571454331663
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14895,477,1.12 [0.95-1.32],0.1708796015670761
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14743,325,0.90 [0.70-1.14],0.3778614159974115
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17997,45,1.30 [0.84-2.01],0.2437276338675421
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18717,4299,1.01 [0.96-1.08],0.6412183473657791
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19146,11,0.63 [0.13-3.19],0.5812243132602462
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19155,20,0.85 [0.31-2.34],0.7535885400670355
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19728,1451,0.96 [0.87-1.05],0.3814116242178468
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19724,1446,0.96 [0.87-1.06],0.4122139287691581
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19146,11,1.77 [1.05-2.97],0.0306477746083061
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19639,674,1.02 [0.88-1.19],0.747238016236321
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15729,1311,1.03 [0.93-1.15],0.5447677726493811
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19856,195,1.00 [0.75-1.33],0.9860942189857944
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19095,82,0.81 [0.48-1.36],0.4277695784581329
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19027,62,0.66 [0.34-1.27],0.2115437451678798
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19039,74,1.03 [0.65-1.61],0.9133429704379544
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14472,54,0.82 [0.44-1.54],0.5443059670126472
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17535,137,0.94 [0.65-1.37],0.7580442388175666
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2105,101,0.91 [0.59-1.40],0.6546400400403952
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,265,0.82 [0.62-1.09],0.1784239471539161
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17476,78,0.95 [0.58-1.56],0.8307877440523959
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2060,56,0.96 [0.56-1.65],0.8818621507044637
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19234,1836,1.04 [0.94-1.14],0.4494488994534149
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19279,266,0.95 [0.73-1.22],0.6712471964628647
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18147,195,1.15 [0.90-1.46],0.2670820418870694
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15037,619,1.19 [1.04-1.36],0.0129302688515333
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19755,201,1.03 [0.79-1.35],0.8158863441089559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18868,231,1.18 [0.93-1.49],0.176114137522179
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,17475,1223,1.03 [0.92-1.15],0.6399700460021414
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18963,326,1.14 [0.93-1.40],0.2142965420050062
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18702,65,1.11 [0.69-1.80],0.6681426131284794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18825,188,1.32 [1.06-1.65],0.0123197804720812
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11632,1869,0.98 [0.89-1.08],0.6974787095136714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,AV-block,16066,498,0.98 [0.81-1.17],0.7871907263014897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19805,429,1.05 [0.87-1.26],0.6198409131893168
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,9968,205,1.11 [0.86-1.44],0.4048180669207251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15733,165,0.59 [0.39-0.90],0.0152534870700427
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15656,88,0.86 [0.52-1.40],0.5403662935650627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19865,48,0.67 [0.32-1.40],0.2825184218147375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,16679,1111,1.00 [0.88-1.12],0.9660057495432708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18401,2168,1.06 [0.98-1.15],0.1294468746291339
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16814,6487,0.98 [0.93-1.03],0.3431708919820032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18846,220,1.09 [0.86-1.40],0.466188498054051
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Endocarditis,15638,70,0.78 [0.44-1.38],0.3902620254916242
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19601,1081,0.96 [0.85-1.09],0.5582948335941582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,17803,5646,0.97 [0.92-1.03],0.3257655427039511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17809,5652,0.97 [0.92-1.03],0.3115998927323581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19675,97,1.22 [0.89-1.69],0.2148913772667158
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12321,164,0.92 [0.65-1.29],0.6219904297549974
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12249,92,0.88 [0.54-1.42],0.5984677273746706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,19745,971,0.92 [0.80-1.05],0.2156829239004501
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18998,95,0.76 [0.46-1.25],0.2812622854996517
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18511,2259,1.05 [0.97-1.14],0.2236330417350052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19528,539,0.95 [0.79-1.13],0.5531285438241209
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15910,342,0.94 [0.74-1.18],0.5820073215784698
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19278,885,1.06 [0.93-1.20],0.3838093854924034
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17016,764,1.09 [0.96-1.25],0.1765238901247151
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19728,187,0.96 [0.71-1.30],0.7891391748224509
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19821,316,1.20 [0.99-1.44],0.0587149024137332
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,18682,56,1.01 [0.58-1.73],0.984259197211169
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other aneurysm,18708,71,1.16 [0.76-1.78],0.4837580259125007
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,15971,403,1.08 [0.89-1.30],0.4221137391092504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18744,107,1.05 [0.71-1.56],0.7909763863317173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18862,225,1.28 [1.03-1.59],0.0238176541859434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15718,150,1.27 [0.98-1.65],0.0694472553884231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other disorders of veins,18698,72,1.11 [0.72-1.70],0.6386141574410228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18667,41,1.29 [0.80-2.09],0.3032262508374841
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18570,75,1.21 [0.84-1.74],0.3001790536429354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18712,86,1.00 [0.66-1.51],0.983400444615412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16586,1018,1.04 [0.93-1.18],0.4942490045282489
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18827,53,0.82 [0.43-1.54],0.5354931033805435
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19093,456,1.15 [0.97-1.37],0.0999264709735048
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19329,307,0.95 [0.75-1.21],0.6841433169226039
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19035,540,1.01 [0.85-1.20],0.8969379666040957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10068,305,0.99 [0.79-1.25],0.9462053764491865
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19012,415,1.10 [0.91-1.33],0.3219652984604486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18911,285,1.05 [0.84-1.31],0.6566753167905779
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19428,406,0.95 [0.78-1.17],0.6567184164790321
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19812,576,1.03 [0.88-1.21],0.7060388669199535
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15960,392,1.04 [0.85-1.27],0.7009181767769386
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19328,306,0.95 [0.75-1.21],0.6870597944104929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18674,179,0.94 [0.68-1.29],0.7005835988528668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19515,612,0.92 [0.78-1.10],0.3664237179502118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19504,637,0.91 [0.76-1.08],0.2638616610838225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18983,39,0.37 [0.14-0.97],0.044275985856197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18732,96,0.91 [0.58-1.41],0.6728791407779188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19183,194,1.03 [0.78-1.36],0.832911870530803
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18653,260,0.92 [0.71-1.20],0.5441684823670967
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,18939,313,1.00 [0.80-1.26],0.9685038621859016
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18653,61,1.30 [0.87-1.94],0.2080006124094985
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19655,633,0.98 [0.84-1.15],0.8284276612491912
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19692,405,1.15 [0.97-1.37],0.1108869299882399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17120,815,0.98 [0.85-1.13],0.7767765546714374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,19284,2979,0.99 [0.92-1.06],0.7721470946660484
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19639,474,1.09 [0.92-1.29],0.3279368300258914
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17259,954,0.95 [0.83-1.09],0.463930499957714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16369,64,1.17 [0.78-1.78],0.448960915126027
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,19312,1287,0.91 [0.81-1.03],0.1403481609282522
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17856,1551,0.98 [0.88-1.08],0.666818021494084
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Vascular dementia,19486,118,1.26 [0.94-1.67],0.1177397298554287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Alzheimer disease,19864,242,0.94 [0.72-1.23],0.6596800652475487
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13287,46,1.12 [0.65-1.91],0.6844271580161527
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Bell's palsy,18725,67,1.26 [0.88-1.80],0.1983108521070142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18948,290,0.99 [0.79-1.25],0.9660881077795924
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral cysts,19534,195,1.09 [0.83-1.42],0.5425529322736133
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19790,275,0.91 [0.70-1.19],0.4997898405542529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19463,55,1.20 [0.77-1.86],0.4188462593717528
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19849,66,1.19 [0.80-1.78],0.3866802855549228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19415,76,1.17 [0.80-1.73],0.4184971753914812
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,18539,228,0.86 [0.64-1.16],0.3192315725891442
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19428,1117,0.95 [0.84-1.07],0.4155716811264259
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19832,392,1.31 [1.13-1.52],0.0003812604611674
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19406,1760,1.03 [0.94-1.13],0.4737823187862944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Generalized epilepsy,19551,48,0.78 [0.39-1.55],0.4764506171583149
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,19729,214,0.83 [0.61-1.14],0.2594625164221678
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hydrocephalus,19387,48,1.04 [0.60-1.80],0.8885889206809922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19848,49,0.99 [0.56-1.74],0.9664209131332804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18678,20,1.15 [0.53-2.49],0.7172626744135953
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18737,79,0.85 [0.51-1.41],0.5251628683892093
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Memory loss,19353,102,1.26 [0.92-1.71],0.1457233086767452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,18472,161,1.15 [0.89-1.50],0.2912718444628288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19844,146,1.18 [0.91-1.54],0.2089917263396657
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Motor neuron disease,13390,137,0.97 [0.69-1.36],0.8477938961783734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19765,57,0.66 [0.33-1.30],0.2282170386397558
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19465,807,0.98 [0.85-1.13],0.7487459439106623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,18761,2927,1.01 [0.94-1.09],0.7598841603445876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19589,181,0.91 [0.66-1.26],0.5816420956300573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18962,304,0.92 [0.72-1.17],0.4878258914292406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19790,287,1.12 [0.91-1.38],0.3011159011774666
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15687,504,0.94 [0.78-1.13],0.5161636460303958
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19402,63,0.85 [0.48-1.50],0.5757970140330199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19462,123,1.03 [0.74-1.46],0.8443155161017373
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19549,109,1.53 [1.23-1.91],0.0001471920171867
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18742,84,1.16 [0.81-1.66],0.4308934597345555
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other headache syndromes,18344,33,0.88 [0.41-1.90],0.7517642905316488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,19767,428,1.10 [0.92-1.31],0.3084898785914302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,18889,578,0.89 [0.75-1.06],0.2061053502040749
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Parkinson's disease,19843,264,1.22 [1.00-1.49],0.0446416025080453
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19361,22,1.49 [0.93-2.38],0.0961981225482921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Restless leg syndrome,19863,35,1.42 [0.91-2.23],0.1250094493225423
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,19622,524,0.91 [0.77-1.09],0.3188126867910762
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19550,47,1.18 [0.72-1.93],0.5136807151065405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19847,157,0.94 [0.68-1.31],0.7174096859468607
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18686,28,0.93 [0.42-2.07],0.8584730741884068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19864,245,0.95 [0.73-1.24],0.7029013788418124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19459,114,1.29 [0.97-1.71],0.0773465560642955
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19421,67,0.68 [0.36-1.26],0.2210630578403099
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19578,240,0.99 [0.77-1.28],0.9517129985260164
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19714,246,0.90 [0.69-1.19],0.4669851751621472
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19132,34,0.73 [0.31-1.70],0.4609537316852736
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19150,52,1.10 [0.68-1.77],0.6940241784013603
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19790,35,1.25 [0.75-2.10],0.3964517098087152
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19676,102,0.77 [0.48-1.24],0.2866198456771655
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2060,56,0.97 [0.56-1.65],0.9001768239526412
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2511,106,0.92 [0.61-1.39],0.7020390930396077
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19434,80,0.76 [0.45-1.30],0.3203085691677068
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19673,825,0.91 [0.78-1.05],0.193334087803838
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19601,503,0.92 [0.76-1.11],0.3839434680572173
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19213,115,0.92 [0.62-1.37],0.6879629258470896
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19803,465,1.03 [0.86-1.23],0.7312620272437648
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19862,54,0.58 [0.28-1.22],0.1510951670778189
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19751,413,1.06 [0.88-1.27],0.529631779772183
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19834,260,0.94 [0.72-1.22],0.6308845230716585
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19790,124,0.89 [0.60-1.31],0.5434938815444862
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19162,64,1.07 [0.68-1.68],0.7664569981406713
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19169,71,0.93 [0.56-1.54],0.7727568489415616
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19132,34,1.25 [0.73-2.13],0.4229507324547424
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19787,571,0.87 [0.72-1.04],0.1281222152423452
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19380,164,0.80 [0.56-1.15],0.2300224828963747
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19360,22,0.85 [0.33-2.21],0.7420668501322502
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19654,80,0.97 [0.61-1.53],0.8873834828071343
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19758,184,0.96 [0.71-1.30],0.7883760322416543
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19485,147,1.20 [0.92-1.57],0.1703892743070745
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19733,67,0.97 [0.60-1.58],0.90873497988921
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19586,370,0.88 [0.70-1.10],0.2596310023022833
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19449,95,1.14 [0.80-1.61],0.473763560240666
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18753,1476,0.93 [0.83-1.04],0.2162105325848956
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19734,160,0.87 [0.62-1.24],0.4476881734803318
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19849,117,0.89 [0.60-1.34],0.5792478446299939
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19443,345,0.90 [0.71-1.13],0.3627674052943103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19631,57,0.92 [0.52-1.62],0.7643513557507738
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19852,44,0.66 [0.30-1.43],0.2892887768446894
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19159,61,1.05 [0.64-1.70],0.8556462744235505
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19222,124,0.77 [0.50-1.19],0.2390307631434513
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18952,104,0.67 [0.40-1.11],0.1200178483079915
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19375,37,0.97 [0.51-1.88],0.9387119590697626
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18898,50,0.45 [0.20-1.01],0.0529387364091048
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19259,43,0.84 [0.43-1.65],0.6134482216990413
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19384,168,0.88 [0.63-1.24],0.4733397348760829
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19186,88,0.85 [0.53-1.38],0.5212502862239136
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18949,101,1.39 [1.09-1.77],0.0081992819893135
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18925,77,0.76 [0.44-1.32],0.3321947086262273
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18466,1189,0.94 [0.83-1.06],0.3356905849620762
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19144,46,1.03 [0.58-1.82],0.923144213250252
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19662,308,0.95 [0.75-1.20],0.6586796724293745
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19410,56,1.05 [0.63-1.75],0.8410326155523968
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19476,122,1.00 [0.70-1.43],0.9886155653766672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19710,50,0.51 [0.23-1.13],0.097018730192593
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19828,104,0.93 [0.61-1.41],0.7297183250173247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19751,95,0.68 [0.40-1.15],0.1524990545395951
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19704,44,1.03 [0.58-1.84],0.9104820463658954
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19706,46,0.88 [0.46-1.68],0.6952219477305815
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19780,764,0.85 [0.72-1.00],0.0452570190747447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19587,571,0.86 [0.71-1.03],0.1021729790207919
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19123,107,0.82 [0.52-1.28],0.3734218890135923
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19082,66,0.96 [0.58-1.59],0.8719916265557902
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute pharyngitis,19686,46,0.84 [0.43-1.66],0.622949176118762
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19794,154,1.05 [0.78-1.43],0.7383165572184824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19690,50,0.85 [0.45-1.61],0.6210348079168937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza,18019,83,0.86 [0.53-1.41],0.5574120932092725
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18016,80,0.78 [0.46-1.34],0.3714225862292583
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13037,87,1.32 [0.98-1.77],0.0674874195480417
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic rhinitis,19777,228,0.97 [0.75-1.26],0.8183616923572433
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13861,1197,1.10 [0.99-1.21],0.0739316115421644
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14126,1176,1.09 [0.98-1.21],0.1051306737786368
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19538,119,1.12 [0.80-1.57],0.4985744252491214
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18008,72,1.13 [0.73-1.74],0.5771540389762553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bronchiectasis,17253,238,1.11 [0.87-1.40],0.4088963146740809
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17051,36,0.57 [0.22-1.44],0.2360756355977331
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19144,2129,1.07 [0.98-1.16],0.1234354542264717
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18648,68,0.85 [0.49-1.47],0.5610938826754028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,18711,131,1.29 [1.00-1.67],0.0526047558033161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19680,1080,1.01 [0.89-1.15],0.8468407946121215
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,18705,125,0.98 [0.69-1.40],0.9171647552777112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18173,4350,1.01 [0.95-1.07],0.7299079710556653
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18913,333,1.08 [0.88-1.32],0.4605084222891026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,18865,265,0.79 [0.58-1.07],0.123497921718068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Emphysema,17313,298,1.04 [0.82-1.31],0.7413604903295594
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19072,295,1.09 [0.88-1.35],0.4343652540321792
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19655,1719,1.06 [0.96-1.16],0.252496018680704
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,19092,315,1.11 [0.90-1.36],0.3343523061806561
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Later onset COPD,18949,815,1.06 [0.93-1.22],0.373615124297073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19848,324,0.78 [0.60-1.02],0.0671184497597127
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,18708,128,1.01 [0.71-1.42],0.9712407712566375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19632,796,0.83 [0.71-0.98],0.0269760264727358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,19630,1818,1.00 [0.91-1.10],0.9401733849989932
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19316,736,1.02 [0.89-1.18],0.777113245250116
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other pleural conditions,17861,49,1.03 [0.59-1.78],0.9298786319093426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19770,387,1.16 [0.97-1.38],0.1017981708361621
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19759,1154,1.03 [0.92-1.16],0.6002825083414549
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,18726,914,1.04 [0.92-1.18],0.5445637578693143
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural plaque,18034,222,0.87 [0.64-1.17],0.3470416422612715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19443,1507,1.06 [0.96-1.17],0.2494087142813517
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19762,238,0.85 [0.64-1.14],0.2861509638918466
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumothorax,17931,119,0.88 [0.59-1.31],0.537473719143736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pollen allergy,19849,195,0.90 [0.67-1.22],0.4989771652763451
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,19441,58,1.18 [0.76-1.84],0.4695272523028448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12995,45,1.06 [0.61-1.85],0.8240005225072305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19617,781,0.85 [0.72-0.99],0.0426026536096134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18809,229,0.97 [0.74-1.26],0.8071075777483829
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Viral pneumonia,18163,227,0.98 [0.75-1.29],0.8973961485267802
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19558,193,1.03 [0.77-1.37],0.8332325946449959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8714,90,1.17 [0.82-1.67],0.3933692584568993
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13909,73,0.96 [0.60-1.56],0.884442680548148
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,19754,122,1.07 [0.77-1.50],0.6804882820220328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute gastritis,15056,70,0.85 [0.49-1.46],0.5506476022026856
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,18735,172,0.81 [0.57-1.15],0.2390704104701241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute peritonitis,19567,77,1.07 [0.70-1.63],0.7713494944341863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19103,91,1.01 [0.67-1.54],0.944752307739002
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Barrett oesophagus,15413,427,0.97 [0.80-1.18],0.7478784302707695
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18665,102,1.08 [0.75-1.55],0.6746338799053292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19519,102,1.08 [0.76-1.56],0.6619279929908982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,18742,179,0.87 [0.62-1.21],0.4079667785893559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,19224,661,1.07 [0.92-1.23],0.3801851285587211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,15198,212,0.80 [0.58-1.10],0.171990156504851
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18612,49,1.02 [0.58-1.80],0.9390802652771504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19693,115,0.93 [0.63-1.37],0.7046146118334498
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,18489,72,1.75 [1.43-2.14],4.9820949110429744e-08
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Collagenous colitis,18661,41,0.43 [0.17-1.08],0.0731974846041312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19717,185,0.82 [0.59-1.16],0.2620798424034209
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,19733,1270,0.98 [0.88-1.10],0.7683987032960128
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,18697,77,0.59 [0.32-1.10],0.0954593532869904
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19570,56,0.62 [0.30-1.26],0.1850263362439852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18685,65,0.59 [0.30-1.16],0.1269971137558596
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,19327,184,0.87 [0.63-1.22],0.4270124865029527
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16855,1596,1.04 [0.95-1.14],0.4085142865033493
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,19780,148,1.06 [0.78-1.43],0.7248436161701665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,19748,736,1.09 [0.95-1.25],0.2146820347876647
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18191,3205,0.99 [0.92-1.06],0.7934256121972926
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19558,415,1.02 [0.84-1.23],0.865243077598295
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19825,335,1.06 [0.87-1.30],0.545659759977097
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19232,89,1.10 [0.75-1.61],0.6294255948574892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19121,51,1.59 [1.20-2.10],0.0011512642324088
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19601,1184,1.16 [1.05-1.28],0.0038631377667883
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of tongue,19132,95,0.85 [0.54-1.35],0.4902501643404244
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19565,1002,0.99 [0.88-1.13],0.9218281479710814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16392,2556,0.94 [0.87-1.03],0.1765162913137643
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,15199,213,0.63 [0.44-0.90],0.011645922726891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19765,165,0.63 [0.41-0.95],0.0281789537662181
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19804,35,0.77 [0.34-1.71],0.5154248560155924
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19146,134,1.11 [0.82-1.51],0.4872021333989095
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13985,149,0.85 [0.58-1.23],0.3827547219580013
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,15334,348,0.85 [0.67-1.08],0.1873000447236548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,15295,309,0.92 [0.72-1.17],0.489156709742072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16752,1766,0.99 [0.90-1.08],0.7664872325611706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15476,490,0.82 [0.67-1.01],0.0678644944533138
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15186,6621,1.00 [0.95-1.05],0.9098108887240294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,19395,978,1.07 [0.95-1.21],0.2703746846862267
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19185,42,1.26 [0.80-1.98],0.3225541726036391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14604,998,0.88 [0.77-1.01],0.0701820708238688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19082,70,0.87 [0.51-1.48],0.5954041708730806
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,18165,2906,1.04 [0.97-1.12],0.2594594859685275
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,19807,34,0.73 [0.32-1.68],0.4608129919821326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impaction of intestines,13870,34,1.26 [0.75-2.12],0.3831037224971513
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,16618,1359,1.02 [0.92-1.13],0.7476274813513893
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15418,159,1.05 [0.78-1.41],0.7307658062205471
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,13912,76,0.71 [0.40-1.25],0.2377248138881701
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18501,84,1.67 [1.36-2.05],8.92745490167813e-07
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14075,239,0.88 [0.66-1.16],0.3676561366333312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19827,314,1.12 [0.92-1.36],0.2577874715207841
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19177,557,0.97 [0.82-1.16],0.7673719991018736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19355,735,0.96 [0.82-1.12],0.5854301806627449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15162,176,0.87 [0.63-1.22],0.4270896173547063
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,15509,523,0.99 [0.83-1.18],0.8880119577452636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19816,90,1.28 [0.94-1.74],0.1173995584319038
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15321,62,1.20 [0.79-1.83],0.3840034441748057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15043,1207,1.01 [0.90-1.13],0.8579302463142271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18779,216,0.92 [0.69-1.23],0.5691947101814212
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18664,101,1.12 [0.79-1.57],0.5343735684649346
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,15407,1571,0.92 [0.83-1.03],0.1420584076793935
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,18346,4510,0.98 [0.92-1.04],0.4489236137264887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19102,148,1.22 [0.95-1.58],0.1228280497450636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,19599,587,1.13 [0.98-1.31],0.0936577210232819
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15586,600,0.97 [0.83-1.15],0.748583476391927
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18678,115,0.81 [0.53-1.25],0.3495480589314036
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19772,282,1.03 [0.82-1.29],0.7950522875128162
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15643,657,0.94 [0.80-1.10],0.4513487470303496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19404,987,1.07 [0.95-1.21],0.2813405780812809
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19286,143,1.24 [0.95-1.61],0.1082063910631842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15136,1300,0.99 [0.88-1.10],0.795585826832204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16518,1532,1.00 [0.90-1.10],0.9524736202318363
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19091,79,0.91 [0.57-1.48],0.7156703985419071
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19260,640,0.94 [0.80-1.11],0.4959343745358998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14121,285,0.83 [0.63-1.08],0.1659787079741399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19795,43,0.73 [0.35-1.54],0.4077148406638182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14227,391,0.89 [0.72-1.11],0.2952640344144654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18561,144,1.26 [0.98-1.63],0.0714299131459245
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19851,34,1.13 [0.63-2.04],0.6883154618020024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19149,84,1.00 [0.65-1.53],0.9943024637039468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Toxic colitis,18656,36,0.70 [0.30-1.62],0.4087747214494541
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15237,251,1.04 [0.82-1.33],0.7242541004265638
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,18746,126,1.00 [0.70-1.42],0.9977261334157708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18725,105,0.90 [0.58-1.37],0.6128226118994532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,15553,294,0.78 [0.59-1.03],0.0747154771932301
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13967,131,1.00 [0.71-1.42],0.9934586988352648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,15472,213,1.04 [0.80-1.35],0.7784451580040828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Volvulus,13896,60,1.28 [0.86-1.91],0.2149392086747541
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19811,262,1.18 [0.96-1.45],0.1238857480540343
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19609,60,0.72 [0.38-1.37],0.3160982759663069
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18236,80,1.13 [0.77-1.67],0.5287436614419511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19249,625,0.96 [0.82-1.14],0.6577850908037202
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18792,168,1.16 [0.90-1.50],0.2502288545446182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18518,362,1.18 [0.99-1.41],0.0668374939410391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19621,218,1.11 [0.88-1.41],0.3779156961176516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19785,382,1.10 [0.91-1.32],0.3144146322661684
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19440,37,1.11 [0.62-1.98],0.7326276031538987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18613,2597,1.00 [0.93-1.08],0.986290362070102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19481,335,0.86 [0.68-1.10],0.2369735674459384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19384,238,0.73 [0.53-1.00],0.0535048096677597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19469,845,1.04 [0.91-1.18],0.5781996645476014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19854,24,0.98 [0.43-2.24],0.9601799800119672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18179,23,1.06 [0.48-2.34],0.8879547786524356
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19196,50,1.15 [0.72-1.85],0.5573088037146039
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19617,214,1.11 [0.87-1.42],0.3842674943783571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18556,400,0.95 [0.77-1.16],0.5970281320435686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18223,67,0.68 [0.37-1.27],0.225579849411199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19811,66,1.08 [0.68-1.70],0.7533700729910411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18786,162,0.96 [0.69-1.33],0.7947134809291397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19723,174,0.85 [0.60-1.20],0.346971622037599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19457,54,1.10 [0.67-1.78],0.709498437811387
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18208,52,0.53 [0.24-1.14],0.1020987034493821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19481,1325,1.05 [0.95-1.17],0.3118569913014326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18593,437,0.94 [0.77-1.15],0.5598588631212326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18226,70,0.78 [0.44-1.38],0.3905375595555574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19790,241,0.93 [0.71-1.22],0.6076858710313616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19449,46,1.16 [0.69-1.95],0.575114526446246
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19760,211,0.94 [0.70-1.25],0.6657694787109331
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19826,277,1.14 [0.92-1.40],0.2327958675669166
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18232,76,1.18 [0.81-1.73],0.3809775723344635
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18375,219,1.07 [0.83-1.37],0.6123551417181171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19821,272,1.15 [0.93-1.42],0.1865646611683345
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18361,205,1.12 [0.89-1.41],0.3378915036057917
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19843,98,1.00 [0.67-1.50],0.9878480461149276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17121,71,1.07 [0.68-1.66],0.7813318998432437
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18116,3935,0.97 [0.91-1.04],0.3931374897958433
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16955,2774,0.93 [0.86-1.00],0.0582730395084503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17115,65,1.28 [0.89-1.83],0.1853953200024506
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17464,120,0.67 [0.42-1.07],0.090001151008728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17461,117,1.06 [0.75-1.50],0.7350551856617136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19687,53,0.86 [0.47-1.59],0.6279324340333273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17410,66,0.71 [0.38-1.32],0.2758794208172017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14903,722,0.91 [0.78-1.06],0.2342338516905031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19760,125,0.94 [0.65-1.36],0.7484683450541318
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17558,214,1.14 [0.90-1.45],0.2630211880942771
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16902,5171,0.99 [0.93-1.04],0.6235163313294502
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19008,80,1.18 [0.82-1.71],0.3638417986569838
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17185,135,1.15 [0.85-1.55],0.370095595791531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17426,376,0.90 [0.72-1.13],0.374314281786706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19172,1828,1.02 [0.94-1.12],0.601019945408782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17363,313,1.00 [0.80-1.25],0.997242634616338
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17097,47,1.13 [0.69-1.85],0.6265253296684546
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17135,85,0.67 [0.39-1.16],0.1553397116824132
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19596,26,1.04 [0.50-2.16],0.908048654940797
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15368,1187,0.92 [0.82-1.04],0.1796704226006689
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14973,792,1.04 [0.91-1.19],0.5502418621550563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19750,779,1.03 [0.90-1.18],0.6315459997166273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14217,36,1.18 [0.69-2.03],0.5396639248113391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14250,69,0.90 [0.54-1.50],0.6927770677605727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17272,222,0.90 [0.67-1.20],0.4637587742785676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14697,516,0.97 [0.81-1.15],0.6966230317146269
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17374,30,1.39 [0.85-2.26],0.1864056828145774
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17774,430,1.02 [0.84-1.23],0.872410539124011
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17557,213,0.79 [0.57-1.09],0.1526814628863864
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14663,482,0.97 [0.81-1.17],0.7764335222913317
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17105,55,0.80 [0.42-1.51],0.4855644711865148
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17091,41,0.93 [0.48-1.80],0.8346117681806574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19001,73,0.69 [0.38-1.26],0.2307808095035587
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19622,694,1.04 [0.90-1.20],0.6334017855473362
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19245,317,1.10 [0.90-1.35],0.338890738680866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19798,250,1.22 [1.00-1.49],0.0462666136986145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15723,1542,0.98 [0.88-1.08],0.6454253824904872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14222,41,0.89 [0.46-1.74],0.7432312564120114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17113,63,0.80 [0.44-1.44],0.4530211848404982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14230,49,1.28 [0.84-1.97],0.2533221577242625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14217,36,1.00 [0.52-1.92],0.9915241929837671
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19083,155,0.91 [0.65-1.29],0.6013349329758899
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19057,129,1.13 [0.83-1.54],0.4277285016404818
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19835,69,0.93 [0.56-1.55],0.7849330319663013
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18587,1243,1.01 [0.91-1.13],0.8189183730061828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17104,54,0.78 [0.41-1.48],0.4392414577576436
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14216,35,1.18 [0.68-2.05],0.5484903019615763
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17853,509,0.97 [0.81-1.17],0.7790808017878491
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15585,1404,0.95 [0.86-1.06],0.400428663099503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19612,42,0.99 [0.53-1.83],0.9630714925616388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19851,55,0.75 [0.39-1.44],0.3871463986270249
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17121,71,0.98 [0.60-1.59],0.9348684513125748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17860,810,1.06 [0.93-1.21],0.3487604138056603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17126,76,1.20 [0.82-1.75],0.3383569642658008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15178,997,1.01 [0.90-1.15],0.825088382429817
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19000,72,1.01 [0.64-1.59],0.974915895034859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17087,37,1.00 [0.53-1.90],0.9965119636744656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17440,96,0.99 [0.66-1.50],0.9748597693232396
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17460,410,1.07 [0.89-1.29],0.446167285246655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19733,163,0.97 [0.70-1.33],0.8300407672746737
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17743,399,0.97 [0.79-1.19],0.7423039401773548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19806,247,1.21 [0.98-1.48],0.0695966582503539
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19851,32,0.93 [0.44-1.96],0.8563692536697176
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17176,126,1.01 [0.71-1.44],0.9432574979379716
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16310,468,0.95 [0.78-1.15],0.5785559809487287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17445,395,1.10 [0.92-1.32],0.3054230480560057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17334,284,0.92 [0.71-1.18],0.5012465979772232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14206,25,0.66 [0.23-1.85],0.4273919860623006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16054,1873,1.06 [0.97-1.16],0.1678235843822426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14548,367,0.89 [0.71-1.10],0.2858900935029855
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19705,135,0.89 [0.61-1.29],0.5262172023128312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19801,35,1.05 [0.56-1.97],0.8679780629112336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18230,35,0.55 [0.22-1.41],0.2128516762519479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14238,57,0.74 [0.39-1.41],0.3550822761904968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17417,73,1.06 [0.68-1.65],0.7941299100618087
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14437,256,1.25 [1.03-1.51],0.0270184548303676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17291,241,1.04 [0.82-1.33],0.7441834877521789
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17520,176,0.87 [0.62-1.22],0.4134515904639787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17410,66,1.05 [0.66-1.68],0.8329792296338103
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15807,26,1.51 [0.93-2.46],0.0959854940575341
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19852,33,1.20 [0.68-2.12],0.5202275940975009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17494,444,1.01 [0.84-1.21],0.9264057367217609
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19587,17,0.89 [0.30-2.59],0.8258289525787159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18955,1905,1.00 [0.92-1.10],0.9607397226351864
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17138,88,1.07 [0.72-1.59],0.7219243584539285
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17748,404,0.89 [0.72-1.11],0.2914387578916622
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18971,170,0.94 [0.68-1.29],0.6935216913967546
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17459,115,1.08 [0.77-1.52],0.6416267963282173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18421,1077,0.98 [0.86-1.11],0.7118418416717862
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18005,661,1.04 [0.90-1.21],0.5770774847730824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17082,32,0.70 [0.29-1.71],0.4385646797623274
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19605,35,1.16 [0.65-2.07],0.614957787020429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17158,108,0.89 [0.58-1.36],0.59045052227751
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17066,16,0.73 [0.20-2.60],0.6236231885798287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14231,50,1.42 [1.00-2.02],0.0520375528273537
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19133,1482,0.96 [0.86-1.07],0.43635958694707
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19463,329,1.08 [0.88-1.31],0.4669874923409113
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19257,123,0.98 [0.68-1.40],0.894968291571897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18765,1114,1.04 [0.93-1.17],0.4959153769071501
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19670,45,1.14 [0.68-1.91],0.6254059050144776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19666,284,1.22 [1.01-1.47],0.0378118858097668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,17523,167,0.85 [0.60-1.21],0.3679249278922328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dialysis,17714,63,1.01 [0.61-1.68],0.97082928388393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.94 [0.87-1.02],0.1367408673692292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17951,4605,1.00 [0.95-1.06],0.9008129560191668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19695,70,0.98 [0.61-1.58],0.9412637293546302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.66 [0.45-0.97],0.0331903034734613
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17724,288,0.98 [0.78-1.25],0.8939429795064667
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.95 [0.87-1.04],0.2746965060199738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.73 [0.52-1.04],0.0792648421986887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17416,60,0.78 [0.42-1.45],0.4239393981951138
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,0.89 [0.57-1.38],0.5962716137298687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19858,52,0.75 [0.38-1.48],0.4045479372210494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19858,41,1.37 [0.90-2.10],0.143611602063656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19178,1822,0.97 [0.88-1.07],0.530345827040005
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18155,799,0.90 [0.77-1.05],0.1664086442531007
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19811,429,1.23 [1.05-1.43],0.00889110591559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.89 [0.68-1.16],0.3899061323552736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,0.88 [0.66-1.17],0.3822845101517523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,0.88 [0.64-1.22],0.4451570769327496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19854,41,0.83 [0.40-1.70],0.6051767515457547
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18571,1215,1.01 [0.90-1.13],0.8739729106119457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17758,322,0.95 [0.75-1.19],0.638461112846606
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19526,144,1.20 [0.91-1.58],0.2025670122068822
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19678,53,1.01 [0.59-1.73],0.9579643034319416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,1.17 [0.93-1.46],0.1761353830527197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19658,2222,0.98 [0.90-1.07],0.6414367239764409
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17488,52,0.99 [0.57-1.73],0.9677424972705836
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17761,110,0.87 [0.57-1.34],0.5264586739558296
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19197,63,1.01 [0.62-1.64],0.9786831287414436
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17604,248,0.85 [0.64-1.13],0.2557142286426027
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19568,434,1.05 [0.88-1.26],0.5655596586574705
